LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
Minnesota MN
Legislatures
2025-2026 Regular Session
Senate
Bills
SF3087
MN
Minnesota Senate Bill SF3087
Minnesota 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
MN
Minnesota 2025-2026 Regular Session
Minnesota Senate Bill SF3087
Introduced
3/27/25
Refer
3/27/25
Caption
Restrictions placed on the sale of certain over-the-counter allergy medications modifications
Latest MN SF3087 Activity
View All Events: MN 2025-2026 Regular Session SF3087
Companion Bills
MN HF2476
Similar To Over-the-counter allergy medicine sale restrictions modified.
Previously Filed As
MN HF2476
Over-the-counter allergy medicine sale restrictions modified.
MN HB563
Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.
MN HB1614
Adds certain 7-OH products to the list of Schedule I controlled substances
MN HB2828
Adds certain psychoactive substances to the list of Schedule I controlled substances and modifies the offenses of possession of a controlled substance and delivery of a controlled substance
MN A864
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
MN S2036
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
MN SB1605
Makes 7-hydroxymitragynine in certain amounts a Schedule I controlled substance
MN S3945
Revises restrictions on sale of hemp products and intoxicating hemp beverages through November 2026.
MN A4791
Revises restrictions on sale of hemp products and intoxicating hemp beverages through November 2026.
MN A3131
Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.
Similar Bills
No similar bills found.